OncoCyte Corporation (NASDAQ:OCX) Q3 2023 Earnings Call Transcript

OncoCyte Corporation (NASDAQ:OCX) Q3 2023 Earnings Call Transcript November 9, 2023

OncoCyte Corporation beats earnings expectations. Reported EPS is $-0.81, expectations were $-1.52.

Operator: Thank you for standing by. My name is Tamika and I will be your conference operator today. At this time, I would like to welcome everyone to the OncoCyte Third Quarter 2023 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there...